140. A Dedicated Colorectal Cancer Center in a VA Medical Center Provides Higher Quality of Care for Colorectal Cancer Patients

2009 ◽  
Vol 151 (2) ◽  
pp. 238
Author(s):  
J.A. Wilks ◽  
C. Liebig ◽  
S.H. Tasleem ◽  
K. Haderxhanaj ◽  
S. Awad ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Quality Of Care ◽  
Cancer Patients ◽  
Medical Center ◽  
Cancer Center ◽  
Colorectal Cancer Patients

Quality of Care of Colorectal Cancer Patients in General Hospitals: Diffusion and Impact of Management Guidelines

1990 ◽  
Vol 76 (3) ◽  
pp. 261-269 ◽  
Author(s):  
Giovanni Apolone ◽  
Roberto Grilli ◽  
Alexan A. Alexanian ◽  
Carlo Confalonieri ◽  
Roberto Labianca ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Quality Of Care ◽  
Cancer Patients ◽  
General Hospitals ◽  
Management Guidelines ◽  
Colorectal Cancer Patients

scholarly journals Chemotherapy treatment: Colorectal cancer patients’ perception

2018 ◽  
Vol 8 (6) ◽  
pp. 85
Author(s):  
Sonia Betzabeth Ticona-Benavente ◽  
Ana Lucia Siqueira Costa
Keyword(s):  
Quality Of Life ◽  
Colorectal Cancer ◽  
Cancer Patients ◽  
Cancer Center ◽  
Chemotherapy Treatment ◽  
Negative Experience ◽  
Effective Interventions ◽  
Colorectal Cancer Patients ◽  
Patient’S Perception

Background and objective: The chemotherapy cause greater impact in the physical and emotional sphere and in the experience of the symptoms. Thus, knowing the perception of these patients, is necessary to obtain subsidies that may direct the implementation of effective interventions for the management of adverse events and the support offering regarding the experience of the disease and treatment, with better impact on the quality of life. The objective of this study was to explore the perception of colorectal cancer patients regarding the chemotherapy treatment.Methods: It is a qualitative study, with content analysis based in Bardin. The sample was composed by 100 patients under chemotherapy treatment for colorectal cancer, who were enrolled in A.C. Camargo Cancer Center, São Paulo, Brazil. The data were collected using an interview about the perception of patients concerning chemotherapy. The interviews were audio recorded. For the analysis, we followed three steps: transcription, codification, and answers categorization.Results: The perceptions of the patients regarding chemotherapy were grouped into four categories: “negative experience”, “necessary for disease control”, “healing treatment” and “positive experience”. The most cited was the negative experience, then, they referred worsening in the emotional level, since they reported sadness, loss of will to perform daily activities, side effects of drugs (hair loss, nausea, diarrhea), and other factors, as well as auxiliary activities necessary to receive treatment.Conclusions: For patients with colorectal cancer, the chemotherapy treatment causes negative experiences that could contribute for abandoning the treatment. However, they refer to be more strengthened and that they have developed the capability of learning through a painful experience as the chemotherapy. Nurses are responsible for valuing the patient's perception in order to make that his/her experience of illness and treatment possible to be reversed in a positive way, so they can have a better quality of life.

Safety and Quality of Life in the Treatment of Non-metastasic Colorectal Cancer Patients: 5-fluorouracil Versus Capecitabine

2019 ◽  
Author(s):  
Julia Sánchez-Gundín ◽  
Cristina Martín-Sabroso ◽  
Ana M. Fernández-Carballido ◽  
D. Barreda-Hernández ◽  
Ana I. Torres-Suárez
Keyword(s):  
Quality Of Life ◽  
Colorectal Cancer ◽  
Cancer Patients ◽  
Colorectal Cancer Patients

scholarly journals Influence of Postoperative Changes in Sarcopenia on Long-Term Survival in Non-Metastatic Colorectal Cancer Patients

Cancers ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 2410
Author(s):  
Chungyeop Lee ◽  
In-Ja Park ◽  
Kyung-Won Kim ◽  
Yongbin Shin ◽  
Seok-Byung Lim ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Medical Center ◽  
The Body ◽  
Term Survival ◽  
Postoperative Changes ◽  
Asan Medical ◽  
Colorectal Cancer Patients

The effect of perioperative sarcopenic changes on prognosis remains unclear. We conducted a retrospective cohort study with 2333 non-metastatic colorectal cancer patients treated between January 2009 and December 2012 at the Asan Medical Center. The body composition at diagnosis was measured via abdominopelvic computed tomography (CT) using Asan-J software. Patients underwent CT scans preoperatively, as well as at 6 months–1 year and 2–3 years postoperatively. The primary outcome was the association between perioperative sarcopenic changes and survival. According to sarcopenic criteria, 1155 (49.5%), 890 (38.2%), and 893 (38.3%) patients had sarcopenia preoperatively, 6 months–1 year, and 2–3 years postoperatively, respectively. The 5-year overall survival (OS) (95.8% vs. 92.1%, hazard ratio (HR) = 2.234, p < 0.001) and 5-year recurrence-free survival (RFS) (93.2% vs. 86.2%, HR = 2.251, p < 0.001) rates were significantly lower in patients with preoperative sarcopenia. Both OS and RFS were lower in patients with persistent sarcopenia 2–3 years postoperatively than in those who recovered (OS: 96.2% vs. 90.2%, p = 0.001; RFS: 91.1% vs. 83.9%, p = 0.002). In multivariate analysis, postoperative sarcopenia was confirmed as an independent factor associated with decreased OS and RFS. Pre- and postoperative sarcopenia and changes in the condition during surveillance were associated with oncological outcomes.

472 Addressing the Quality of Hospital Care of Colorectal Cancer Patients Undergoing Surgery: What Did We Learn from the National Bowel Cancer Audit?

2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
C Li ◽  
S Z Y Ooi ◽  
T Woo ◽  
P H M Chan
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
External Validation ◽  
Distant Metastases ◽  
Management Plan ◽  
Bowel Cancer ◽  
Clinical Factors ◽  
Quality Outcomes ◽  
Colorectal Cancer Patients

Abstract Aim To identify the most relevant clinical factors in the National Bowel Cancer Audit (NBOCA) that contribute to the variation in the quality of care provided in different hospitals for colorectal cancer patients undergoing surgery. Method Data from 36,116 patients with colorectal cancer who had undergone surgery were retrospectively collected from the NBOCA and analysed from 145 and 146 hospitals over two years. A validated multiple linear regression was performed to compare the identified clinical factors with various quality outcomes. The quality outcomes defined in this study were the length of hospitalisation, 2-year mortality, readmission rate, 90-day mortality, and 18-month stoma rate. Results Four clinical factors (laparoscopy rate, abdominal-perineal-resection-of-rectum (APER), pre-operative radiotherapy and patients with distant metastases) were shown to have a significant (p &lt; 0.05) impact on the length of hospitalisation and 18-month stoma rate. 18-month stoma rate was also significantly associated with 2-year mortality. External validation of the regression model demonstrated the Root-Mean-Square-Error of 0.811 and 4.62 for 18-month stoma rate and 2-year mortality respectively. Conclusions Hospitals should monitor the four clinical factors for patients with colorectal cancer during perioperative care. Clinicians should consider these factors along with the individual patients’ history when formulating a management plan for patients with colorectal cancer.

Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?

2009 ◽  
Vol 18 (5) ◽  
pp. 547-555 ◽  
Author(s):  
Johannes Giesinger ◽  
Georg Kemmler ◽  
Verena Mueller ◽  
August Zabernigg ◽  
Beate Mayrbaeurl ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Colorectal Cancer ◽  
Cancer Patients ◽  
Colorectal Cancer Patients ◽  
Disease Specific

Depression, Fatigue, and QoL in Colorectal Cancer Patients During and After Treatment

2016 ◽  
Vol 38 (7) ◽  
pp. 893-908 ◽  
Author(s):  
Hong-Yi Tung ◽  
Tung-Bo Chao ◽  
Yu-Hua Lin ◽  
Shu-Fen Wu ◽  
Hui-Yen Lee ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Colorectal Cancer ◽  
Health Care ◽  
Cancer Patients ◽  
Health Care Professionals ◽  
Nursing Intervention ◽  
Prevalence Of Depression ◽  
Study Population ◽  
Colorectal Cancer Patients

In this study, we sought to explore the prevalence of depression and fatigue in colorectal cancer patients during and after treatment to examine how these variables affect quality of life (QoL). In total, 170 patients with colorectal cancer participated in this study. The study population was divided into two groups: one receiving treatment and another that had finished treatment. The results showed that depression and fatigue measurements were higher in patients receiving treatment. Depression was a strong and significant predictor of QoL in both groups, whereas fatigue was not, with the exception of the symptom score. These findings underscore the importance of early detection and management of depression and fatigue during the treatment and survival stages of patients with colorectal cancer. Our findings indicate that health care professionals should provide appropriate nursing intervention to decrease depression and fatigue and enhance patient QoL.

Sign in / Sign up

Export Citation Format

Share Document